Coinstar Shares Up 7% On Report
Shares of Coinstar Inc. , parent of DVD kiosk operator Redbox, were up 7% Thursday after the New York Post reported that the company has been in talks with a private-equity firm about a possible sale for several months.
Ecopetrol Sells $1.2 Billion of Crude to Essar -Reuters
Colombia's Ecopetrol SA (EC) has made a $1.2 billion deal to sell 12 million barrels of its Castilla crude oil over the course of a year to India's Essar Oil Ltd. (500134.BY), Reuters reported, citing Ecopetrol and a source.
Discover Adds Google Wallet Button for Card Customers
Discover Financial Services (DFS) is making it easier for its credit-card customers to use Google Inc.'s (GOOG) new pay-by-phone service.
Cisco Leads the Street Higher
After some early apprehension, Wall Street turned solidly positive Thursday morning amid enthusiasm for Cisco's upbeat guidance and a rally in the materials sector.
Judge Allows Assured Guaranty to Proceed With Suit Against UBS -Reuters
Assured Guaranty Ltd. (AGO) can proceed with suing UBS AG (UBS) for misrepresenting the quality of loans underlying $1.49 billion of mortgage-backed securities it insured, Reuters reported Thursday citing a federal ruling.
Brazil Vale CEO: Iron-Ore Prices to Recover in September
International iron-ore prices are set to recover in September, Murilo Ferreira, chief executive of Brazilian mining company Vale SA (VALE, VALE5.BR) said Thursday.
Cablevision Signs Multiyear Deal to Carry NFL Network
Cablevision Systems Corp. (CVC) has struck a multiyear deal with the National Football League to carry its NFL Network and NFL RedZone channels, adding some of the most highly valued sports content to Cablevision's lineup in time for the upcoming football season.
Analyst Blames 'media Hype' For Facebook Sell-off
Facebook Inc.'s stock decline on Thursday is the result of investors "succumbing to media hype" and not the case of "lockup sellers selling," Wedbush analyst Michael Pacther said in an interview Thursday.
FDA Puts Idenix Hepatitis Drug on Partial Hold
Regulators dealt Idenix Pharmaceuticals Inc. (IDIX) a new setback, placing a partial hold on further trials of its hepatitis C drug after a similar compound from rival Bristol-Myers Squibb Co. (BMY) raised concerns about the treatments' heart safety.